Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
OpenUrlCrossRefPubMedWeb of Science
Q Does a combination of olanzapine and fluoxetine lead to a greater reduction in symptoms in people with treatment resistant depression compared with either drug alone?
Multicentre randomised controlled trial.
Follow up period:
Seventy one sites in the United States and Canada; study started in August 1999.
500 people (age 18–65 years) with treatment resistant unipolar, non-psychotic, major depression disorder (DSM-IV; Montgomery-Åsberg Depression Rating Scale (MADRS) total score ⩾20). Participants had not responded to a selective serotonin reuptake inhibitor in the past, and also failed to respond to nortriptyline (<30% reduction in …
For correspondence: Richard C Shelton, MD, Department of Psychiatry, Vanderbilt University, 1500 21st Avenue South, Nashville, TN 37212, USA;
Source of funding: Eli Lilly and Company.